Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (199)	12/10/1997 5:05:00 PM
From: James Crawford	Respond to of 1494

If NTII is delisted, what would be the impact on small investors? Would it be fatal for the stock if this happens before any positive news is forthcoming on memantine? Any informed predictions would be appreciated. As a shareholder I've never faced this situation before.

To: Dr. John M. de Castro who wrote (199)	12/10/1997 10:13:00 PM
From: JMarcus	Respond to of 1494

Someone must share your belief in Memantine. The stock rebounded 33.25% today. What a roller coaster ride!

To: Dr. John M. de Castro who wrote (199)	12/10/1997 10:38:00 PM
From: John Dwyer	Read Replies (1) \| Respond to of 1494

Thanks John, I agree with the idea that this is related to tax-loss selling. The threat of delisting combined with NTII's cash crunch makes this stock an easy target. John, do you think that a secondary is really the best idea for NTII? To fund a Phase III trial they need significant cash... a secondary would imply a high degree of dilution. Wouldn't a partnership be better for them? Do you think there is any chance of a decent deal considering NTII's weakened finacial state? Perhaps they are waiting for the results before striking a deal. Comments? John